10 20 30 40 50 60 70 80 2IOX - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER 11-OCT-06 2IOX
TITLE RHEUMATOID ARTHRITIS-RELATED ANTIGEN RA-A47
COMPND MOL_ID: 1; COMPND 2 MOLECULE: THESE ARE NOT LIGANDS. THE ARE CAPPING GROUPS; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THESE ARE CAPPING GROUPS
KEYWDS RHEUMATOID ARTHRITIS
EXPDTA THEORETICAL MODEL
AUTHOR RAMAKRISHNA ANNABHIMOJU,DR. V.UMA
REVDAT 1 24-OCT-06 2IOX 0
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2IOX COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998
REMARK 100 REMARK 100 THIS ENTRY WAS DEPOSITED AT RCSB ON 11-OCT-2006. REMARK 100 THE RCSB ID CODE IS RCSB039834.
REMARK 220 REMARK 220 EXPERIMENTAL DETAILS REMARK 220 EXPERIMENT TYPE : THEORETICAL MODELLING REMARK 220 REMARK 220 REMARK: THIS THEORETICAL MODEL ENTRY WAS NOT ANNOTATED AND NOT REMARK 220 VALIDATED BY THE WWPDB STAFF AND THEREFORE MAY NOT REMARK 220 CONFORM TO THE PDB FORMAT.
REMARK 225 REMARK 225 THEORETICAL MODEL REMARK 225 THE COORDINATES IN THIS ENTRY REPRESENT A MODEL STRUCTURE. REMARK 225 PROTEIN DATA BANK CONVENTIONS REQUIRE THAT CRYST1 AND REMARK 225 SCALE RECORDS BE INCLUDED, BUT THE VALUES ON THESE REMARK 225 RECORDS ARE MEANINGLESS.
REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 NMA A 376 C4 P O1P O2P O4P C5A C5 REMARK 470 NMA A 376 N1 C6 C2 C2A C3 O3 C8 REMARK 470 NMA A 376 C7 O7 O8 C9 C10
REMARK 888 REMARK 888 WRITTEN BY MAESTRO (A PRODUCT OF SCHRODINGER, LLC)
SEQRES 1 A 337 ACE ALA THR LEU ALA GLU ARG SER ALA GLY LEU ALA PHE SEQRES 2 A 337 SER LEU TYR GLN ALA MET ALA LYS ASP GLN ALA VAL GLU SEQRES 3 A 337 ASN ILE LEU VAL SER PRO VAL VAL VAL ALA SER SER LEU SEQRES 4 A 337 GLY LEU VAL SER LEU GLY GLY LYS ALA THR THR ALA SER SEQRES 5 A 337 GLN ALA LYS ALA VAL LEU SER ALA GLU GLN LEU ARG ASP SEQRES 6 A 337 GLU GLU VAL HIS ALA GLY LEU GLY GLU LEU LEU ARG SER SEQRES 7 A 337 LEU SER ASN SER THR ALA ARG ASN VAL THR TRP LYS LEU SEQRES 8 A 337 GLY SER ARG LEU TYR GLY PRO SER SER VAL SER PHE ALA SEQRES 9 A 337 ASP ASP PHE VAL ARG SER SER LYS GLN HIS TYR ASN CYS SEQRES 10 A 337 GLU HIS SER LYS ILE ASN PHE ARG ASP LYS ARG SER ALA SEQRES 11 A 337 LEU GLN SER ILE ASN GLU TRP ALA ALA GLN THR THR ASP SEQRES 12 A 337 GLY LYS LEU PRO GLU VAL THR LYS ASP VAL GLU ARG THR SEQRES 13 A 337 ASP GLY ALA LEU LEU VAL ASN ALA MET PHE PHE LYS PRO SEQRES 14 A 337 HIS TRP ASP GLU LYS PHE HIS HIS LYS MET VAL ASP ASN SEQRES 15 A 337 ARG GLY PHE MET VAL THR ARG SER TYR THR VAL GLY VAL SEQRES 16 A 337 MET MET MET HIS ARG THR GLY LEU TYR ASN TYR TYR ASP SEQRES 17 A 337 ASP GLU LYS GLU LYS LEU GLN ILE VAL GLU MET PRO LEU SEQRES 18 A 337 ALA HIS LYS LEU SER SER LEU ILE ILE LEU MET PRO HIS SEQRES 19 A 337 HIS VAL GLU PRO LEU GLU ARG LEU GLU LYS LEU LEU THR SEQRES 20 A 337 LYS GLU GLN LEU LYS ILE TRP MET GLY LYS MET GLN LYS SEQRES 21 A 337 LYS ALA VAL ALA ILE SER LEU PRO LYS GLY VAL VAL GLU SEQRES 22 A 337 VAL THR HIS ASP LEU GLN LYS HIS LEU ALA GLY LEU GLY SEQRES 23 A 337 LEU THR GLU ALA ILE ASP LYS ASN LYS ALA ASP LEU SER SEQRES 24 A 337 ARG MET SER GLY LYS LYS ASP LEU TYR LEU ALA SER VAL SEQRES 25 A 337 PHE HIS ALA THR ALA PHE GLU LEU ASP THR ASP GLY ASN SEQRES 26 A 337 PRO PHE ASP GLN ASP ILE TYR GLY ARG GLU GLU NMA
HET ACE A 40 6 HET NMA A 376 5
HETNAM ACE ACETYL GROUP HETNAM NMA N-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4- HETNAM 2 NMA YLMETHYL]-2-METHYLALANINE
HETSYN NMA N-PYRIDOXYL-2-METHYLALANINE-5-PHOSPHATE
FORMUL 1 ACE C2 H4 O FORMUL 1 NMA C12 H19 N2 O7 P
HELIX 1 1 ALA A 41 GLN A 62 1 22 HELIX 2 2 SER A 70 GLY A 85 1 16 HELIX 3 3 LYS A 86 LEU A 97 1 12 HELIX 4 4 SER A 98 ARG A 103 5 6 HELIX 5 5 GLU A 106 SER A 119 1 14 HELIX 6 6 ALA A 143 TYR A 154 1 12 HELIX 7 7 ARG A 167 THR A 181 1 15 HELIX 8 8 HIS A 215 VAL A 219 5 5 HELIX 9 9 LEU A 278 LEU A 284 1 7 HELIX 10 10 THR A 286 MET A 294 1 9 HELIX 11 11 LEU A 317 GLY A 325 1 9
SHEET 1 A 8 HIS A 158 ILE A 161 0 SHEET 2 A 8 LYS A 129 PRO A 137 1 N LEU A 134 O SER A 159 SHEET 3 A 8 LEU A 199 PHE A 206 -1 O PHE A 205 N LYS A 129 SHEET 4 A 8 PHE A 366 GLU A 375 -1 O ILE A 370 N ASN A 202 SHEET 5 A 8 TYR A 347 LEU A 359 -1 N ALA A 356 O ASP A 367 SHEET 6 A 8 GLN A 298 ASP A 316 -1 N HIS A 315 O HIS A 353 SHEET 7 A 8 THR A 231 ASP A 248 -1 N MET A 235 O LYS A 308 SHEET 8 A 8 ASP A 220 MET A 225 -1 N PHE A 224 O VAL A 232 SHEET 1 B 9 HIS A 158 ILE A 161 0 SHEET 2 B 9 LYS A 129 PRO A 137 1 N LEU A 134 O SER A 159 SHEET 3 B 9 LEU A 199 PHE A 206 -1 O PHE A 205 N LYS A 129 SHEET 4 B 9 PHE A 366 GLU A 375 -1 O ILE A 370 N ASN A 202 SHEET 5 B 9 TYR A 347 LEU A 359 -1 N ALA A 356 O ASP A 367 SHEET 6 B 9 GLN A 298 ASP A 316 -1 N HIS A 315 O HIS A 353 SHEET 7 B 9 THR A 231 ASP A 248 -1 N MET A 235 O LYS A 308 SHEET 8 B 9 LEU A 253 PRO A 259 -1 O GLU A 257 N ASN A 244 SHEET 9 B 9 SER A 266 PRO A 272 -1 O MET A 271 N GLN A 254
CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 1.000000 0.000000 0.000000 0.00000
SCALE2 0.000000 1.000000 0.000000 0.00000
SCALE3 0.000000 0.000000 1.000000 0.00000